EUVIMEDEUVIMED entdecken
Crossref

Why are the First-Line Therapies Used as Injections Discontinued in the Treatment of Multiple Sclerosis?

Sedat ŞEN, Murat TERZİ

International Archives of Medical Research · 2022

DOI: 10.56484/iamr.1087921 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Archives of Medical Research, 2022. Verfasst von Sedat ŞEN und 1 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben. Gefördert von: Yok.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Immunomodulatory therapies (IMTs) are used in the treatment of multiple sclerosis (MS) considering their efficacy and safety. Although other effective treatments have been used in recent years, the use of IMTs still continues. In this study, we aimed to reveal the reasons for the discontinuation of IMTs used as injections.

Method

IMTs data of 1464 patients were collected and analysed from the Imed database, where 20-year data of the patients were entered by us. Groups were divided as; Interferon beta-1a subcutaneous (IFN-β1a SC), Interferon beta-1a intramuscular (IFN-β1a IM), glatiramer acetate (GA) and Interferon beta-1b (IFN-β1b). Age, gender, duration of illness, types of disease onset, time to start the injection, duration of injection therapy, and reason for discontinuation of patients were analysed.

Results

The most common reason for discontinuation of treatments was found to be disease progression (20.13%, 28.14%, 19.64%, 23.87%). Side effects, increased attack frequency, patient demand, disease activity detection in imaging methods, and pregnancy planning followed the disease progression respectively.

Conclusion

IMTs as an injection form are used in the treatment of MS, considering their effectiveness and reliability. The most common reason for discontinuing treatment is disease progression.

Förderung

  • Yok

Zitieren

APA

ŞEN, S., & TERZİ, M. (2022). Why are the First-Line Therapies Used as Injections Discontinued in the Treatment of Multiple Sclerosis?. International Archives of Medical Research. https://doi.org/10.56484/iamr.1087921

Vancouver

ŞEN S, TERZİ M. Why are the First-Line Therapies Used as Injections Discontinued in the Treatment of Multiple Sclerosis?. International Archives of Medical Research. 2022. doi:10.56484/iamr.1087921

BibTeX
@article{EN2022,
  author = {ŞEN, Sedat and TERZİ, Murat},
  title = {Why are the First-Line Therapies Used as Injections Discontinued in the Treatment of Multiple Sclerosis?},
  journal = {International Archives of Medical Research},
  year = {2022},
  doi = {10.56484/iamr.1087921}
}
Kostenlos starten →